Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHuEpo before autologous stem cell transplantation to reduce transfusion needs
2007-005831-27Phase 3Active
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of erythropoietin in anaemia, sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoint: Number of red blood cell units transfused during bone marrow aplasia. Started May 2008; status: active.
02
Drugs
erythropoietin
03
Conditions
anaemia
Beyond the preview
Go deeper on 2007-005831-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005831-27.